News article

The latest stories about hormones

European Medicines Agency recommends suspension of marketing authorisations for sibutramine (EMA Press release, 21 January 2010)

22 Jan 2010


The European Medicines Agency has released a press release recommending the Europe-wide suspension of the anti-obesity drug sibutramine. The recommendation follows findings from a 6-year trial that linked the drug with an increased risk of non-fatal heart attack and stroke.

Press release

EMA homepage


Contents